SMS is Becoming a Must Have in Omnichannel Activation to Help Amplify and Connect Other Resources
Exploring the Current State and Potential of Direct Messaging
The brand benefits of working with Impiricus
Every brand faces a constant stream of changes that is ideally communicated with HCPs as quickly as possible.
The Pharma results when working with Impiricus
The HCP preferred engagement platform and the only SMS proprietary network
The Evolution of HCP Engagement
Consequences and Opportunities for Biopharma Brand Strategies and Tactics
Impiricus Raises $3M in Seed Funding Led by FCA Venture Partners
In 2022, Impiricus closed a $3 million Series Seed financing round led by FCA Venture Partners, with participation from Surface Ventures. “Impiricus clearly fits our investment thesis,” said Todd Johnson, Partner at FCA Venture Partners. “A bold leadership team with a powerful product and the potential to reshape pharma-HCP collaboration.” The funding supports our ongoing […]
